comparemela.com

Latest Breaking News On - Cash runway - Page 6 : comparemela.com

Ovid Therapeutics and Ligand Pharmaceuticals Enter into a $30 Million Agreement for a 13% Interest in Soticlestat Royalties and Milestones Extending Ovid s Cash Runway into 2026

Ovid Therapeutics and Ligand Pharmaceuticals Enter into a $30 Million Agreement for a 13% Interest in Soticlestat Royalties and Milestones Extending Ovid s Cash Runway into 2026
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

TriSalus Life Sciences Completes Merger with MedTech Acquisition Corporation

TriSalus Life Sciences Completes Merger with MedTech Acquisition Corporation
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

Iterum Therapeutics Reports Second Quarter 2023 Financial Results

Iterum Therapeutics Reports Second Quarter 2023 Financial Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Kineta Reports Second Quarter 2023 Financial Results and Provides Corporate Update

11.08.2023 - Initial Clinical Data Readout from Ongoing Phase 1/2 Study of VISTA-Targeting KVA12123 in Advanced Solid Tumors Anticipated by End of 2023 Received $5 Million Research and Development Collaboration Milestone Payment from Merck Cash Runway into .

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.